Synthesis and N-Methyl-D-aspartate (NMDA) Receptor Activity of Ketamine Metabolites

被引:65
|
作者
Morris, Patrick J. [1 ]
Moaddel, Ruin [2 ]
Zanos, Panos [3 ]
Moore, Curtis E. [4 ]
Gould, Todd [3 ,5 ,6 ]
Zarate, Carlos A., Jr. [7 ]
Thomas, Craig J. [1 ]
机构
[1] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA
[2] NIA, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA
[3] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA
[4] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[5] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA
[6] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA
[7] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, Bethesda, MD 20892 USA
关键词
ANTIDEPRESSANT; MECHANISMS; DEPRESSION; AMINATION; CURRENTS; PLASMA;
D O I
10.1021/acs.orglett.7b02177
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Ketamine is rapidly metabolized in the human body to a variety of metabolites, including the hydroxynorketamines. At least two hydroxynorketamines have significant antidepressant action in rodent models, with limited action against the N-methyl-D-aspartate (NMDA) receptor. The synthesis of 12 hydroxynorketamines and their binding affinity to the NMDA receptor is presented here.
引用
收藏
页码:4572 / 4575
页数:4
相关论文
共 50 条
  • [1] Synthesis and N-Methyl-D-aspartate (NMDA) Receptor Activity of Ketamine Metabolites (vol 19, pg 4572, 2017)
    Morris, Patrick J.
    Moaddel, Ruin
    Zanos, Panos
    Moore, Curtis E.
    Gould, Todd D.
    Zarate, Carlos A., Jr.
    Thomas, Craig J.
    ORGANIC LETTERS, 2017, 19 (19) : 5494 - 5494
  • [2] N-methyl-D-aspartate (NMDA) receptor: friend or foe?
    Robichon, Regine
    Ticku, Maharaj K.
    Indian Journal of Experimental Biology, 1998, 36 (10): : 947 - 959
  • [3] Longterm treatment of chronic neuropathic pain with the NMDA (N-methyl-D-aspartate) receptor antagonist ketamine
    Stubhaug, A
    Breivik, H
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1997, 41 (03) : 329 - 331
  • [4] N-methyl-D-aspartate (NMDA) encephalitis
    Molnar, P.
    BRAIN PATHOLOGY, 2014, 24 : 10 - 10
  • [5] IS THE SITE OF ACTION OF KETAMINE ANESTHESIA THE N-METHYL-D-ASPARTATE RECEPTOR
    YAMAMURA, T
    HARADA, K
    OKAMURA, A
    KEMMOTSU, O
    ANESTHESIOLOGY, 1990, 72 (04) : 704 - 710
  • [6] Anti-NMDA (N-methyl-D-aspartate Receptor) receptor encephalitis
    Engen, Kristine
    Agartz, Ingrid
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (11) : 1006 - 1009
  • [7] COMPETITIVE ANTAGONISM OF GLYCINE AT THE N-METHYL-D-ASPARTATE (NMDA) RECEPTOR
    HUETTNER, JE
    BIOCHEMICAL PHARMACOLOGY, 1991, 41 (01) : 9 - 16
  • [8] Mechanism of Regulation of the N-Methyl-D-Aspartate (NMDA) Receptor Activity in the Normoxic Newborn Brain
    Alan B Zubrow
    Santina Zanelli
    Wenxin Wei
    Om P Mishra
    Maria Delivoria-Papadopoulos
    Pediatric Research, 1999, 45 : 72 - 72
  • [9] Mechanism of regulation of the N-methyl-D-aspartate (NMDA) receptor activity in the normoxic newborn brain
    Zubrow, AB
    Zanelli, S
    Wei, WX
    Mishra, OP
    Delivoria-Papadopoulos, M
    PEDIATRIC RESEARCH, 1999, 45 (04) : 72A - 72A
  • [10] Ketamine and other N-methyl-D-aspartate receptor modulators in treatment of depression
    Vestring, Stefan
    Domschke, Katharina
    Normann, Claus
    NERVENARZT, 2022, 93 (03): : 234 - 242